Due to the practical limitations of migration and invasion assays, we could not determine conclusively whether the combined antimigratory/invasive effect of IL‐6 Ab and Box5 treatment on BRAFi‐R melanoma cells was additive or synergistic. This evidence concerns the gene IL6 and melanoma.